Bleeding Risk with Concomitant Use of NSAIDs and Apixaban

Introduction to Bleeding Risk

• The British Society of Gastroenterology guidelines state that NSAIDs should be avoided in patients taking direct oral anticoagulants like apixaban, as their concomitant use was associated with increased bleeding risk in clinical trials 1

Patient Management

• The American Family Physician guidelines identify acetaminophen as appropriate for pain management in patients requiring anticoagulation, unlike NSAIDs which carry significant bleeding warnings 2
• Acetaminophen is considered safe with apixaban and does not increase bleeding risk, making it the analgesic of choice for anticoagulated patients 3

Special Considerations

• The combination of apixaban and NSAIDs poses particular danger in elderly patients, those with renal impairment, patients with prior bleeding history, or those on concurrent antiplatelet therapy 1, 2
• Consider adding proton pump inhibitor (PPI) prophylaxis to reduce gastrointestinal bleeding risk, though this does not eliminate the systemic bleeding risk 2

Monitoring and Emergency Care

• Monitor closely for signs of bleeding including unusual bruising, prolonged bleeding from cuts, blood in urine or stool, or unexplained bleeding 3
• Seek emergency care immediately for unusual bleeding or bruising, particularly if severe or unexplained 3